Chi-Ying Huang

24PUBLICATIONS
55CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNanotoxicology, health and safetyEcosystem services (incl. pollination)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Mar 05, 2026
Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screens.

Tiger Haoran Shi, Yu-Tang Huang, Hyunsu Jeon

|Aug 05, 2025
Targeting GPX4 to Overcome Sorafenib Resistance of Human Hepatocellular Carcinoma by Inducing Ferroptosis.

Han-Hsuan Tang, Chi-Pei Hsu, Pin-Yu Su

|Feb 26, 2025
Prevention and Treatment of Peritoneal Dialysis-Associated Fibrosis with Intraperitoneal Anti-Fibrotic Therapy in Experimental Peritoneal Fibrosis.

Chiao-Yin Sun, Yu-Ting Hsieh, Shang-Chieh Lu

|Jan 27, 2025
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer.

Yen-Han Tseng, Trieu Thi My Tran, Jinghua Tsai Chang

|Jan 25, 2025
Correction: Yeh et al. Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates. Biomedicines 2021, 9, 1582.

Yuan-Chieh Yeh, Bashir Lawal, Michael Hsiao

|Dec 18, 2024
Exploring the Synergistic Effects of Erinacines on Microglial Regulation and Alzheimer's Pathology Under Metabolic Stress.

Van Thanh Bui, Kuan-Wei Wu, Chin-Chu Chen

Pageof 4

Frequent Collaborators

8 joint publications

Michael Hsiao

3 joint publications

Yuan-Chieh Yeh

2 joint publications

Hsiu-Jung Liao

2 joint publications

Ian Yi-Feng Chang